PURPOSE: To investigate the etiologic distribution of hemoptysis in patients admitted to the hospital and to determine the relationship between etiology and the amount and recurrence of hemoptysis.
METHODS: The records of patients who were admitted to the hospital because of hemoptysis in years 2008-2009 were retrospectively investigated. The amount of hemoptysis was considered as mild (<30 ml/day), moderate (30-100 ml/day), severe (100-600 ml/day) and massive (>600 ml/day).Any hemoptsis restricted in last 1 month was considered as “new” whereas hemoptysis recurring for more than 1 month was considered “recurring”. Chi-square was used in the statistical analysis.
RESULTS: Records of 101 patients were included in the study: 29(28.7%) female and 72(71.3%) male with a mean age of 53.7±17.2. In 90.1% (n=91) hemoptysis was new whereas it was recurring in 9.9% (n=10) patients. A great majority of cases were belonging to”mild” hemoptysis (n=90, 89%) group. Moderate, severe and massive hemoptysis was in 3,6 an 2 patients , respectively. Lung cancer(%40.6, n=41) was the leading cause of hemoptysis followed by pneumonia(%14.9, n=15), pulmonary embolism(%6.9, n=7) and lung metastasis of extrapulmonary malignancies(%5.9, n=6). In 13(%12.9) cases, the etiology has remained unknown. There was no statistically significant relationship between benign and malignant etiology regarding “amount” and “recurrence” of hemoptysis (p>0.05).
CONCLUSIONS: Malignant diseases constituted almost half of etiologies in patients hospitalized because of hemoptysis. The specifications of hemoptysis were not contributing the etiologic diagnosis, at least in the present series.
CLINICAL IMPLICATIONS: The differential diagnosis of hemoptysis in hospitalized patients
DISCLOSURE: The following authors have nothing to disclose: Sevda Comert, Coskun Dogan, Serap Diktas, Ali Fidan, Nesrin Kiral, Gulsen Sarac, Benan Caglayan
No Product/Research Disclosure Information